Sophia Nozick

7PUBLICATIONS
33CO-AUTHORS
Medical microbiology not elsewhere classifiedMedical infection agents (incl. prions)Infant and child healthMicrobiology not elsewhere classifiedPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2026
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.

|Aug 19, 2026
Comparison of Galleria mellonella, epithelial cell cytotoxicity, and mouse model of bacteremia to measure Pseudomonas aeruginosa virulence.

|May 29, 2026
Identification of Streptococcus pyogenes isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitis.

|Apr 10, 2026
A novel mechanism of ceftolozane-tazobactam resistance in Pseudomonas aeruginosa mediated by L2 β-lactamase.

Preeti Garai, Sophia H Nozick, Caroline C Jozefczyk

|Dec 29, 2025
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia.

Marta Zurawska, Adrian Valadez, Emma Harlan

|Dec 29, 2025
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia.

Ryan Williamson, Marta Zurawska, Adrian Valadez

Pageof 2

Frequent Collaborators

7 joint publications

Alan R Hauser

6 joint publications

Egon A Ozer

4 joint publications

Nathaniel J Rhodes

2 joint publications

Marta Zurawska